KNSA +28.5%, AMC +24.6% Lead EPS Revision Gainers on July 29
Kiniksa Pharmaceuticals (KNSA) jumped 28.5% after an upward EPS revision to 39.7% growth, reinforced by strong Q2 results and raised ARCALYST guidance. AMC surged 24.6% following a 14.2pp EPS revision and record revenue of $1.6B. Cleveland-Cliffs (CLF) rose 23.5% on an 11.5pp EPS revision and a Q3 outlook doubling EBITDA, while Baozun (BZUN) gained 24.6% on a 2.2pp revision despite no company news. FIRY advanced 15.7% aided by a $719M legal victory.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| KNSA | Healthcare | 2026-07-23 | N/A | +28.5% |
| BZUN | Consumer Cyclical | 2026-07-24 | +2.2pp | +24.6% |
| AMC | Communication Services | 2026-07-21 | +14.2pp | +24.6% |
| CLF | Basic Materials | 2026-07-21 | +11.5pp | +23.5% |
| FIRY | Communication Services | 2026-07-21 | N/A | +15.7% |
Why did KNSA stock jump in July 2026?
KNSA jumped 28.5% (from $63.05 to $81.04) after analysts raised its forward EPS growth estimate to 39.7% on July 23.
The upgrade was validated by Kiniksa's Q2 2026 earnings on July 28, which showed ARCALYST revenue up 55% YoY to $243.6M and raised full-year guidance to $980–$995M. The company also advanced its pipeline with KPL-387 Phase 2 data supporting a pivotal trial. The screener caught the revision early, and the market rewarded the stock with a 28.5% gain over six sessions.
KNSA EPS revision history → · Screener snapshot from 2026-07-23 →
FAQ: KNSA
Why did KNSA stock jump?
KNSA surged 28.5% after analysts raised its forward EPS growth estimate to 39.7% and the company reported strong Q2 results with ARCALYST sales beating expectations.
Is KNSA a buy after the rally?
The EPS revision and raised guidance suggest continued momentum, but investors should consider the stock's elevated valuation after the 28.5% gain.
What caused KNSA's surge?
The primary catalyst was an upward EPS estimate revision on July 23, followed by Q2 earnings that showed 55% revenue growth and a guidance raise.
Why did BZUN stock jump in July 2026?
BZUN jumped 24.6% (from $2.48 to $3.09) after analysts raised its forward EPS growth estimate from 58.1% to 60.4% on July 24.
The consumer cyclical stock gained without any company-specific earnings news, suggesting the revision alone drove buying interest. The move may also reflect broader sector momentum as investors rotate into beaten-down consumer names. The screener detected the revision early.
BZUN EPS revision history → · Screener snapshot from 2026-07-24 →
FAQ: BZUN
Why did BZUN stock jump?
BZUN rose 24.6% after analysts revised its forward EPS growth estimate upward from 58.1% to 60.4% on July 24, with no additional news catalysts.
Is BZUN a buy after the rally?
The upward revision signals improving profitability expectations, but the lack of news and the stock's low price suggest caution.
What is BZUN's EPS growth estimate?
BZUN's forward EPS growth estimate was raised to 60.4% from 58.1%, reflecting analyst optimism about the company's earnings trajectory.
Why did AMC stock jump in July 2026?
AMC jumped 24.6% (from $2.20 to $2.74) after analysts raised its forward EPS growth estimate from 42.0% to 56.2% on July 21.
The revision was supported by AMC's record Q2 earnings on July 20, which showed revenue of $1.6B and adjusted EBITDA of $321.4M. CEO Adam Aron pushed back against skeptics during the call. The stock's meme status may have amplified the move, but the fundamental improvement is clear.
AMC EPS revision history → · Screener snapshot from 2026-07-21 →
FAQ: AMC
Why did AMC stock jump?
AMC surged 24.6% after an upward EPS revision of 14.2 percentage points and record Q2 revenue of $1.6 billion.
Is AMC a buy after the rally?
The record revenue and debt reduction improve the fundamental case, but the stock remains volatile with meme-stock characteristics.
What caused AMC's surge?
The primary catalysts were the EPS estimate revision and the company's best-ever quarterly results, including a 70% jump in adjusted EBITDA.
Why did CLF stock jump in July 2026?
CLF jumped 23.5% (from $9.25 to $11.42) after analysts raised its forward EPS growth estimate from 235.3% to 246.8% on July 21.
The steelmaker's Q2 earnings on July 23 showed adjusted EBITDA tripling to $286M, with guidance for Q3 to double that. Automotive demand recovery and Section 232 tariffs are driving higher prices and volumes. The screener detected the revision before the earnings beat.
CLF EPS revision history → · Screener snapshot from 2026-07-21 →
FAQ: CLF
Why did CLF stock jump?
CLF gained 23.5% after an upward EPS revision of 11.5 percentage points and strong Q2 results with EBITDA tripling.
Is CLF a buy after the rally?
The Q3 guidance of $575M EBITDA suggests continued momentum, but steel prices are cyclical; the stock may still have upside if tariffs remain.
What caused CLF's surge?
The combination of an EPS estimate revision, a Q2 earnings beat, and a positive outlook driven by automotive demand and trade policies.
Why did FIRY stock jump in July 2026?
FIRY jumped 15.7% (from $8.82 to $10.20) after analysts raised its forward EPS growth estimate to 27.0% on July 21.
The move was amplified by a federal court order on July 28 requiring Papaya Gaming to pay $719M to FIRY's Skillz subsidiary, far exceeding the earlier jury award. The false advertising win represents a major legal victory and validates the company's competitive moat. The EPS revision and legal catalyst combined to drive the stock higher.
FIRY EPS revision history → · Screener snapshot from 2026-07-21 →
FAQ: FIRY
Why did FIRY stock jump?
FIRY rose 15.7% after an upward EPS revision to 27.0% growth and a $719 million court judgment against a competitor.
Is FIRY a buy after the rally?
The legal win provides a large cash recovery, but investors should assess the company's underlying business growth beyond the one-time gain.
What caused FIRY's surge?
The EPS estimate revision and the surprising court order for $719M in disgorgement were the main catalysts.
Today's performers highlight how upward EPS revisions, especially when confirmed by earnings beats or catalysts, can drive substantial short-term gains. The breadth across sectors suggests a market rewarding fundamental improvement.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →